John L Flavin is of Pyxis Oncology, Inc.. Currently has a direct ownership of 413,015 shares of PYXS, which is worth approximately $697,995. The most recent transaction as insider was on Mar 26, 2024, when has been sold 35,219 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 413K
0% 3M change
9.32% 12M change
Total Value Held $697,995

JOHN L FLAVIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 26 2024
BUY
Grant, award, or other acquisition
-
35,219 Added 7.86%
413,015 Common Stock
Mar 24 2023
BUY
Grant, award, or other acquisition
-
139,355 Added 26.95%
377,796 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
66,831 Added 21.89%
238,441 Common Stock
Oct 13 2021
BUY
Conversion of derivative security
-
2,388 Added 1.37%
171,610 Common Stock
JLF

John L Flavin

Cambridge, MA

Track Institutional and Insider Activities on PYXS

Follow Pyxis Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PYXS shares.

Notify only if

Insider Trading

Get notified when an Pyxis Oncology, Inc. insider buys or sells PYXS shares.

Notify only if

News

Receive news related to Pyxis Oncology, Inc.

Track Activities on PYXS